Business Context and Reporting Period
This Form 8-K filing by Definitive Healthcare Corp. (DH) is dated June 18, 2026. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with listing standards.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The only quantitative metric disclosed is the stock price performance: the closing bid price of the Company's common stock remained below $1.00 per share for 30 consecutive business days from May 6, 2026, to June 17, 2026.
Material Changes
The material change reported is the failure to meet Nasdaq Listing Rule 5450(a)(1), which requires a minimum bid price of $1.00 per share. Consequently, the Company has been notified of its non-compliance with the continued listing requirements for The Nasdaq Global Select Market.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has an initial 180-calendar-day compliance period ending December 15, 2026, to regain compliance.
- Remediation Criteria: Compliance is achieved if the closing bid price is at least $1.00 per share for a minimum of ten consecutive business days during the compliance period.
- Future Options: If the initial period is unsuccessful, the Company may be eligible for an additional 180-day period, provided it meets other listing standards (e.g., market value of publicly held shares) and may effect a reverse stock split.
- Risks: There is no assurance the Company will regain compliance or maintain other listing requirements. Failure to cure the deficiency could result in delisting.
- Current Status: The notice has no immediate effect on trading; the stock will continue to trade under the symbol "DH" during the compliance period.
Investor Verification Checklist
- Verify the current closing bid price of DH stock relative to the $1.00 threshold.
- Monitor the Company's announcements regarding the potential execution of a reverse stock split.
- Review the Company's market value of publicly held shares to assess eligibility for the second compliance period.
- Track the 180-day deadline (December 15, 2026) for regaining compliance.